Abstract:According to the new diagnostic criteria in 2014 ,classical Guillain-Barré syndrome (GBS) and Miller-Fisher syndrome (MFS) belong to GBS spectrum , their diagnosis and differential diagnoses depends largely on specific core clinical features. This research compared the difference between classical GBS and MFS in non-core clinical features , nerve conduction studies and cerebrospinal fluid (CSF ) tests. Methods We retrospectively reviewed results of non-core clinical features ,nerve conduction studies and CSF tests of 37 MFS patients and compared them with 79 classical GBS patients in Renji Hospital from Jan 2013 to Mar 2017. Results (1 ) Non-core clinical features :1 ) Precursor infection :the M FS group had higher rates of precursor respiratory tract infection than the classical GBS group (48.6％ vs. 22.8％ , P<0.01) , however the classical GBS group had higher rates of precursor diarrhea than the MFS group (34.1％ vs. 2.7％ , P< 0.05) , both reached statistical significance. 2) Non-core symptoms :The patients in the MFS group had lower rates of paresthesia than the patients in the classical GBS group (37.8％ vs. 60.8％ , P< 0.05) .3) The Hughes functional grading scale scores (Hughes scores) at the peak of disease :The rate of patients whose Hughes scores≥ 3 (suggest poor outcomes) in the MFS group was lower than the classical GBS group (8.1％ vs. 75.9％ , P<0.01) . (2) Electromyography :1) The major nerve conduction findings in patients with classical GBS were motor and sensory conduction abnormality (54.4％ ) or motor conduction abnormality (27.8％ ) . The major nerve conduction findings in patients with MFS were absent or reduced H-reflexes (approximately 35.1％ ) , sensory conduction abnormality (approximately 35.1％ ) or normal nerve conduction findings (approximately 13.5％ ) , P < 0.05. 2 ) The F wave abnormality were hardly observed in MFS patients (5.4％ ) ,however usually observed in classical GBS patients (82.3％ ) , P< 0.05. (3) Examination of CSF :the classical GBS group (82.4％ ) had higher rates of albuminocytologic dissociation and higher average CSF protein level than the MFS group [82.4％ vs.57.1％ ;χ2 =5.022 , P<0.05 ; (1144.46 ± 764.31) mg/L vs. (691.79 ± 469.35) mg/L ;t= -3.371 , P< 0.01] . Conclusions The rate of patients whose peak Hughes scores≥3 in classical GBS patients is higher than MFS patients , The degree of disability is more serious in classical GBS. Non-core clinical features , electrophysiological and CSF tests besides the accepted specific core clinical features have obvious difference between these two subtypes ,all these can contribute to understanding of the new diagnostic criteria ,which can help to diagnose and identify both.

Miller fisher variant of guillain‐barre syndrome following modified radical mastectomy: a photo essay

Rehabilitation of a 51-Year-Old Patient With Miller Fisher Syndrome: A Case Report

Exploring Treatments for a Rare Guillain-Barré Variant: A Case Report of Miller-Fisher Syndrome

A case report of thrombocytopenic COVID-19 and Miller–Fisher syndrome on a concurrent chronic immune neuropathy

Miller Fisher syndrome following Pfizer COVID-19 vaccine

Course and Treatment of a Rare Neurological Sequelae After COVID-19: Miller Fisher Syndrome

COVID-19-Associated Miller Fisher Syndrome With Long Latency Period: A Case Report

The doctor as patient: an encounter with Guillain-Bárré syndrome

[Miller-Fisher syndrome and the spectrum of oculomotor palsies with anti-GQ1b antibodies]

Miller Fisher syndrome and polyneuritis cranialis in COVID-19

Guillain-Barré Syndrome Following Lung Adenocarcinoma Surgery: A Case Report and Literature Review

Bulbar Paralysis Associated with Miller-Fisher Syndrome and Its Overlaps in Chinese Patients

Choroidal metastases with exudative retinal detachment as the initial presentation of disseminated lung adenocarcinoma: photo essay

Complex Neurological Sequelae: Axonal Guillain-Barré Syndrome Post COVID-19 in a Young Patient

Miller Fisher syndrome associated with COVID-19: an up-to-date systematic review

Ataxia and ophthalmoplegia: an atypical case of Miller Fisher syndrome (MFS) with anti-GAD antibody

The comparison of non-core clinical features , electromyography and cerebrospinal fluid test in Miller-Fisher syndrome and Guillain-Barré syndrome

Refining the Pulmonary and Functional Competencies in a Male Patient With Guillain-Barré Syndrome

Understanding the diagnostic challenges of Miller Fisher syndrome in children: a case report from an ophthalmological perspective

Fish-tail Plasty: A Secure Technique to Enhance Cosmesis at the Lateral End of Mastectomy Scar and Prevent Dog Ear

Choroidal metastases secondary to lung carcinoma: photo essay